›› 2009, Vol. 29 ›› Issue (10): 1246-.

• Review • Previous Articles     Next Articles

Application of metabolomics in malignant tumors

FAN Xing, reviewer;LI Jun-min, CHEN Sai-juan, reviser   

  1. Shanghai Institute of Hematology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China
  • Online:2009-10-25 Published:2009-10-26


Metabolomics is one of the branches of systems biology, which employs nuclear magnetic resonance and mass spectrometry technologies to detect the abnormal metabolites from a variety of body fluids. Study of various molecules and their functions may help to find the disease-related early metabolic marker clusters, understand the molecular mechanism of pathogenesis, which provides broad prospects for the early diagnosis and individualized treatment of malignant tumors.

Key words: metabolomics, malignant tumor, early diagnosis, biomaker, individualized , treatment

CLC Number: